The following Q&A has been edited for length and clarity. John Carroll: We've had a chance to talk a little bit before here ...
At Klick Health’s first Ideas Exchange conference with biotech and pharma industry insiders since before the pandemic began, ...
The EMA is putting EU member states on alert over the shortage of two drugs that counter heart attacks due to an uptick in ...
Though Moderna’s bivalent vaccine to counter the Omicron variant has cleared the initial hurdles in getting FDA authorization ...
Just one day after blockbuster Lynparza got access to another indication in China, its Big Pharma owners have decided to ...
The FDA's Oncologic Drugs Advisory Committee on Friday voted 8-4 against the benefit-risk profile of Secura Bio's PI3K ...
When Cecilia Jones started at Genzyme, there was next to nothing in Kendall Square. “It was just us,” Jones said. “There wasn ...
Amgen said it was encouraged by the solicitor general’s anticipated review of its Supreme Court petition to rehear a Repatha ...
A Cipla drug manufacturing site in India has once again landed in the crosshairs of FDA inspectors. The facility in question ...
Almost a year after the FDA gave the green light to LA-based Aadi Bioscience's first drug, the biotech is looking to private ...
When vaccines from high-income countries did not arrive in Africa, a local WHO-backed company decided to take the matter into ...
ODAC on Thursday voted overwhelmingly against keeping the accelerated approval for Oncopeptides' Pepaxto, 14 voting ...